IL15 and neuroblastoma: An Onc.Ad expressing both IL-15 and RANTES (Onc.Ad-IL15/RANTES) has demonstrated that combining both molecules can have a profound effect on adoptively transferred GD2.CAR-T cells, which have accomplished remission in patients with neuroblastoma (40).